Biomarkers, surrogate markers, and design of clinical trials of new therapies for systemic lupus erythematosus.
Schiffenbauer
Joel
J
Center for Drug Evaluation and Research, FDA, Rockville, Maryland 20850, USA. schiffenbaue@cder.fda.gov
Hahn
Bevra
B
Weisman
Michael H
MH
Simon
Lee S
LS
D015415:Biomarkers; D002986:Clinical Trials as Topic; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D017063:Outcome Assessment, Health Care; D012107:Research Design
D015415:Biomarkers